New Blog Post:
From Computer to Clinic: How AI Unlocked the Potential of GB-0669
Announcement:
Novartis and Generate:Biomedicines Announce Collaboration
Celebrated on the 2024 CNBC Disruptor 50 List
Contact
Curious about our work? Get in touch.
InvestorsJason Silversinvestors@generatebiomedicines.com
Media InquiriesMegan McLaughlinpr@generatebiomedicines.com
Collaboration & PartnershipsSahm Nasseripartner@generatebiomedicines.com